Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H17NO4 |
| Molecular Weight | 263.2891 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(CN1CCOCC1)OCC(=O)C2=CC=CC=C2
InChI
InChIKey=WIELTBTVQBNULW-UHFFFAOYSA-N
InChI=1S/C14H17NO4/c16-13(12-4-2-1-3-5-12)11-19-14(17)10-15-6-8-18-9-7-15/h1-5H,6-11H2
| Molecular Formula | C14H17NO4 |
| Molecular Weight | 263.2891 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: Farmaco, Edizione Scientifica (1963), 18, (4), 245-53 | Endokrynologia Polska (1962), 13, 73-9.
Sources: Farmaco, Edizione Scientifica (1963), 18, (4), 245-53 | Endokrynologia Polska (1962), 13, 73-9.
Mobecarb is morpholineacetic acid derivative patented by Carlo Erba Societa per Azioni to prevent vascular rupture among persons afflicted with arterial hypertension. In preclinical models Mobecarb shows the capillary protective activity in partially omentectomized rats.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:02:42 GMT 2025
by
admin
on
Mon Mar 31 18:02:42 GMT 2025
|
| Record UNII |
46LG9K0Y24
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C78311
Created by
admin on Mon Mar 31 18:02:42 GMT 2025 , Edited by admin on Mon Mar 31 18:02:42 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
15518-84-0
Created by
admin on Mon Mar 31 18:02:42 GMT 2025 , Edited by admin on Mon Mar 31 18:02:42 GMT 2025
|
PRIMARY | |||
|
27362
Created by
admin on Mon Mar 31 18:02:42 GMT 2025 , Edited by admin on Mon Mar 31 18:02:42 GMT 2025
|
PRIMARY | |||
|
46LG9K0Y24
Created by
admin on Mon Mar 31 18:02:42 GMT 2025 , Edited by admin on Mon Mar 31 18:02:42 GMT 2025
|
PRIMARY | |||
|
1764
Created by
admin on Mon Mar 31 18:02:42 GMT 2025 , Edited by admin on Mon Mar 31 18:02:42 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106776
Created by
admin on Mon Mar 31 18:02:42 GMT 2025 , Edited by admin on Mon Mar 31 18:02:42 GMT 2025
|
PRIMARY | |||
|
DTXSID40165849
Created by
admin on Mon Mar 31 18:02:42 GMT 2025 , Edited by admin on Mon Mar 31 18:02:42 GMT 2025
|
PRIMARY | |||
|
SUB09020MIG
Created by
admin on Mon Mar 31 18:02:42 GMT 2025 , Edited by admin on Mon Mar 31 18:02:42 GMT 2025
|
PRIMARY | |||
|
C66173
Created by
admin on Mon Mar 31 18:02:42 GMT 2025 , Edited by admin on Mon Mar 31 18:02:42 GMT 2025
|
PRIMARY | |||
|
100000080885
Created by
admin on Mon Mar 31 18:02:42 GMT 2025 , Edited by admin on Mon Mar 31 18:02:42 GMT 2025
|
PRIMARY | |||
|
239-551-9
Created by
admin on Mon Mar 31 18:02:42 GMT 2025 , Edited by admin on Mon Mar 31 18:02:42 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |